{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-040339","form_type":"8-K","ticker":"STEX","cik":"0001530766","company_name":"Streamex Corp.","filed_at":"2023-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.394306+00:00","generated_at":"2026-06-08T05:04:09.108460+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BioSig closes $2.5M registered direct offering of stock and warrants; net proceeds ~$2.2M","bullets":["Offered 6,996,922 units (1 share + Series A & B warrants each for 1 share) at $0.3573 per unit.","Gross proceeds $2.5M; net proceeds ~$2.2M; use for working capital and general corporate purposes.","Placement agent H.C. Wainwright receives 7% cash fee and warrants for 489,785 shares at $0.4466.","Series A warrants expire in 5 years, Series B in 18 months; exercisable upon stockholder approval or $0.125 payment.","Closing occurred November 13, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-040339","json":"https://secwatch.observer/filing/0001493152-23-040339.json","markdown":"https://secwatch.observer/filing/0001493152-23-040339.md","text":"https://secwatch.observer/filing/0001493152-23-040339.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1530766/000149315223040339/0001493152-23-040339-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1530766/000149315223040339/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T05:04:09.108460+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b99db2584f3443092dfc38aacd1c698f8df57636","claim":"Streamex Corp. entered into Securities Purchase Agreement with institutional investor valued at 6,996,922 shares of common stock at $0.3573 per share, Series A and Series B warrants, aggregate gro (effective 2023-11-08).","evidence_excerpt":"On November 8, 2023, BioSig Technologies, Inc. (the “Company”), entered into a securities purchase agreement (the “Securities Purchase Agreement”) with an institutional investor, pursuant to which the Company agreed to sell and issue, in a registered direct offering (the “Offering”), (i) 6,996,922 shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”), (ii) Series A warrants (the “Series A Warrants”) to purchase up to 6,996,922 shares of Common Stock, and (iii) Series B Warrants (the “Series B Warrants”, and together with the Series A Warrants, the “Series Warrants”) to purchase up to 6,996,922 shares of Common Stock, at a purchase price of $0.3573 per Share and associated Series Warrants.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315223040339/0001493152-23-040339-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"institutional investor"},{"label":"Value","value":"6,996,922 shares of common stock at $0.3573 per share, Series A and Series B warrants, aggregate gro"},{"label":"Effective","value":"2023-11-08"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}